Dysodia

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

L
LabcorpNC - Burlington
1 program
Singing-voice Disorders and Aerodynamic Profiles in Dysodic SingersN/A1 trial
Active Trials
NCT04036864Unknown100Est. Jun 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
LabcorpSinging-voice Disorders and Aerodynamic Profiles in Dysodic Singers

Clinical Trials (1)

Total enrollment: 100 patients across 1 trials

NCT04036864LabcorpSinging-voice Disorders and Aerodynamic Profiles in Dysodic Singers

Singing-voice Disorders and Aerodynamic Profiles in Dysodic Singers

Start: Mar 2019Est. completion: Jun 2021100 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space